Erratum to: Thioredoxin-Interacting Protein: a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice

Erratum to: Mol Neurobiol

DOI 10.1007/s12035-014-8766-x

The original paper of this article unfortunately contain errors on Figure 4. The images at sham and eMCAO/TKO group panels are the same for both DAPI staining and caspase-1 staining of the sham versus the eMCAO/TKO.

The authors are sorry for these errors and certainly would like to correct the figure. Figure 4 is hereby corrected.

Fig. 4

TXNIP inhibition attenuates NLRP3 inflammasome protein activation at 24 h post-eMCAO. Representative and quantitative analysis of Western blots (a) and immunohistochemical representation around the penumbra (b) showing that NLRP3 expression and immunopositive signals increased after eMCAO and mitigated in RES-treated WT and TKO mice. Representative and quantitative analysis of Western blots of cleaved caspase-1 (c) and cleaved IL-1β (e) and increased and immunohistochemical representation of caspase-1 (d) after eMCAO. The expression of these proteins was attenuated in REStreated WT and TKO mice compared to vehicle-treated WT. Values are expressed as mean±SEM (n=4–6, *P<0.05 WT-shams vs WT-eMCAO, *P<0.05 WT-eMCAO vs. RES-WTeMCAO or TKO-eMCAO)